Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Machaon who wrote (18832)	4/7/1998 4:23:00 PM
From: tonyt	Read Replies (1) \| Respond to of 32384

>Tonyt might've "guessed" the directions of LGND based on some kind >of hocus-pocus. LOL!! Looks like LGND needs some 'hocus-pocus' to 'Breakout!' Two years and almost 19,000 posts later and LGND is still where it was when this thread started. (a) BTW, I've 'guessed' right more than enough times for even you to admit its not 'luck' (....Luck is what LGND shareholders need these days!) LGND is soooooooo predictible -- try looking at the chart. exchange2000.com (a) Today LGND made a major announcement at the Bear Stearns' Biotech conference this morning. One of LGND's retinoids, Targretin, is in advanced clinical trials for a wide range of cancers. Today LGND indicated that pre-clinical data (in mice and rats) suggested additional indications (for type II diabetes and breast cancer). Over 1/2 million shares traded in the first hour and the price has moved to 15 1/4 (from yesterday's close of 13 1/8).